Finding a resveratrol analogue as potential anticancer agent with apoptosis and cycle arrest

J Pharmacol Sci. 2020 Jul;143(3):238-241. doi: 10.1016/j.jphs.2020.03.007. Epub 2020 Mar 23.

Abstract

Resveratrol has been extensively studied as the anti-cancer agent. A variety of resveratrol analogues have been developed with structural modification to improve its bioactivity. In this work, resveratrol analogues, compound 1-4, were designed and synthesized with the Stille-Heck reaction. These results showed compound 1-4 had better anticancer effect than that of parent resveratrol. Especially compound 1 ((E)-4,4'-(ethene-1,2-diyl)bis(3-methylphenol)) displayed the excellent cytotoxicity and high selectivity. The mechanism research indicated compound 1 inhibited cell proliferation by binary paths of cell cycle arrest in S phase regulated by cyclin A1/A2 and apoptosis induction mediated by Bax/Bcl2 in a prooxidant manner.

Keywords: Cell apoptosis; Cell cycle arrest; Resveratrol.

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Cell Cycle Checkpoints / drug effects*
  • Cell Proliferation / drug effects
  • Cell Proliferation / genetics
  • HeLa Cells
  • Humans
  • MCF-7 Cells
  • Neoplasms / pathology*
  • Organic Chemistry Phenomena
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Resveratrol / analogs & derivatives*
  • Resveratrol / chemical synthesis
  • Resveratrol / chemistry
  • Resveratrol / pharmacology*
  • Structure-Activity Relationship
  • bcl-2-Associated X Protein / metabolism

Substances

  • Antineoplastic Agents, Phytogenic
  • BAX protein, human
  • BCL2 protein, human
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-2-Associated X Protein
  • Resveratrol